Physician profile
Robert Forster
NPI 1770554784
$1,305.46
in general payments reported to CMS, 2019-2025
17 companies · $219 in 2025
The $219 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $301 · 2020: $234 · 2021: $117 · 2022: $101 · 2023: $184 · 2024: $149 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $552.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $552.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $321.20 | 2019-2024 | Monovisc, Orthovisc |
| Endo Pharmaceuticals INC. | $270.19 | 2019-2023 | Xiaflex |
| Axogen | $175.48 | 2020-2025 | |
| Pacira Therapeutics, INC. | $103.03 | 2019-2020 | |
| Abbott Laboratories | $70.92 | 2019-2020 | |
| Endo USA, INC. | $70.49 | 2024-2025 | Xiaflex |
| Djo, LLC | $60.69 | 2019-2025 | Cmf |
| Fidia Pharma USA INC. | $40.80 | 2019 | |
| Horizon Therapeutics Plc | $32.08 | 2019 | |
| Bioventus LLC | $29.53 | 2019-2021 | |
| Nevro Corp. | $28.26 | 2024 | Senza |
| Zimmer Biomet Holdings, INC. | $28.15 | 2019 | |
| Orthofix Medical, INC. | $21.47 | 2020 | |
| Sanofi-Aventis U.S. LLC | $15.58 | 2023 | |
| Daiichi Sankyo INC. | $13.04 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $12.35 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $12.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Forster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.